Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 14, 2018 - Issue 2
Submit an article Journal homepage
451
Views
3
CrossRef citations to date
0
Altmetric
Review

Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge

Uwe Klaus ZettlDepartment of Neurology, Neuroimmunology Section, University of Rostock, Rostock, GermanyView further author information
,
Michael HeckerDepartment of Neurology, Neuroimmunology Section, University of Rostock, Rostock, GermanyView further author information
,
Orhan AktasDepartment of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, GermanyView further author information
,
Torsten WagnerDepartment of Medical Affairs, Merck KGaA, Darmstadt, GermanyView further author information
&
Paulus S. RommerDepartment of Neurology, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
View further author information
Pages 137-153 | Received 09 Oct 2017, Accepted 08 Jan 2018, Published online: 23 Jan 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Uwe Klaus Zettl, Paulus Stefan Rommer, Orhan Aktas, Torsten Wagner, Joachim Richter, Patrick Oschmann, Lukas Cepek, Birte Elias-Hamp, Klaus Gehring, Andrew Chan & Michael Hecker. (2023) Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation. Expert Review of Clinical Immunology 19:11, pages 1343-1359.
Read now
Clara G. Chisari, Simona Toscano, Emanuele D’Amico, Salvatore Lo Fermo, Aurora Zanghì, Sebastiano Arena, Mario Zappia & Francesco Patti. (2019) An update on the safety of treating relapsing-remitting multiple sclerosis. Expert Opinion on Drug Safety 18:10, pages 925-948.
Read now
Agnese Gugliandolo, Federica Longo, Maria Giovanna Marrosu, Giovanni Luigi Mancardi, Ilaria Gandoglia, Maurizio Melis, Fabrizio Lo Giudice, Placido Bramanti & Emanuela Mazzon. (2018) A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients. Therapeutics and Clinical Risk Management 14, pages 1765-1788.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.